Gagliardi; Stefania

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gagliardi; Stefania.The latest application filed is for "peptide derivatives and therapeutic activity thereof".

Company Profile

1.17.41

Gagliardi; Stefania - Chignolo d'Isola IT
GAGLIARDI; Stefania - CHIGNOLO D'ISOLA BG
Gagliardi; Stefania - Vimercate IT
Gagliardi; Stefania - Milan IT
Gagliardi; Stefania - Baranzate Di Bollate IT
GAGLIARDI; Stefania - King of Prussia PA
Gagliardi, Stefania - Como IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptide derivatives and therapeutic activity thereof Grant 11,420,943 - Negrisoli , et al. August 23, 2	2022-08-23
Peptide Derivatives And Therapeutic Activity Thereof App 20200361875 - NEGRISOLI; GianPaolo ; et al.	2020-11-19
(R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel Grant 9,284,306 - Gagliardi , et al. March 15, 2	2016-03-15
(R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel Grant 9,067,927 - Gagliardi , et al. June 30, 2	2015-06-30
(R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel App 20150148547 - Gagliardi; Stefania ; et al.	2015-05-28
(R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel App 20150119431 - Gagliardi; Stefania ; et al.	2015-04-30
Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents Grant 8,969,380 - Gagliardi , et al. March 3, 2	2015-03-03
Secondary 8-hydroxyquinoline-7-carboxamide derivatives Grant 8,729,076 - Gagliardi , et al. May 20, 2	2014-05-20
Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof Grant 8,729,098 - Gagliardi , et al. May 20, 2	2014-05-20
Secondary 8-hydroxyquinoline-7-carboxamide Derivatives For Use As Antifungal Agents App 20120329797 - Gagliardi; Stefania ; et al.	2012-12-27
Secondary 8-hydroxyquinoline-7-carboxamide Derivatives App 20120316167 - Gagliardi; Stefania ; et al.	2012-12-13
Tertiary 8-hydroxyquinoline-7-carboxamide Derivatives And Uses Thereof App 20120309751 - Gagliardi; Stefania ; et al.	2012-12-06
Class of histone deacetylase inhibitors Grant 8,242,175 - Mai , et al. August 14, 2	2012-08-14
New Class Of Histone Deacetylase Inhibitors App 20120115867 - Minucci; Saverio ; et al.	2012-05-10
Heterocyclic Derivatives As Hdac Inhibitors App 20110105474 - Thaler; Florian ; et al.	2011-05-05
Class Of Histone Deacetylase Inhibitors App 20110077247 - Mai; Antonello ; et al.	2011-03-31
Class Of Histone Deacetylase Inhibitors App 20100305123 - Thaler; Florian ; et al.	2010-12-02
Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof App 20100173945 - Farina; Carlo ; et al.	2010-07-08
Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof Grant 7,732,473 - Farina , et al. June 8, 2	2010-06-08
Class Of Histone Deacetylase Inhibitors App 20100113438 - Mai; Antonello ; et al.	2010-05-06
Novel Heterocyclic Compounds as Positive Allosteric Modulators of Metabotropic Glutamate Receptors App 20100004284 - Farina; Marco ; et al.	2010-01-07
Substituted indole ligands for the ORL-1 receptor App 20090275555 - Ronzoni; Silvano ; et al.	2009-11-05
Substituted Oxadiazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate Receptors App 20090215822 - Farina; Marco ; et al.	2009-08-27
Pyrrole Derivatives as Positive Allosteric Modulators of Metabotropic Receptors App 20090203737 - Gagliardi; Stefania ; et al.	2009-08-13
Novel Oxadiazole Derivatives and Their Use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors App 20090197897 - Bugada; Piergiuliano ; et al.	2009-08-06
Compounds with nootropic action, their preperation, pharmaceutical compositions containing them, and use thereof App 20090163565 - FARINA; Carlo ; et al.	2009-06-25
Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents Grant 7,544,705 - Farina , et al. June 9, 2	2009-06-09
Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors App 20090082399 - Bugada; Piergiuliano ; et al.	2009-03-26
N-acyl-N'-benzyl-alkylendiamino derivatives Grant 7,411,091 - Thaler , et al. August 12, 2	2008-08-12
Novel Tetrazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate App 20070299110 - Gagliardi; Stefania ; et al.	2007-12-27
3-substituted Quinoline-4-carboxamide Derivatives As Nk-3 And Nk-2 Receptor Antagonists App 20070259882 - FARINA; Carlo ; et al.	2007-11-08
Indole and Azaindole Derivatives with Antitumor Action App 20070248672 - Farina; Carlo ; et al.	2007-10-25
Substituted indole ligands for the orl-1 receptor App 20070197603 - Consonni; Alessandra ; et al.	2007-08-23
QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS App 20070161647 - Farina; Carlo ; et al.	2007-07-12
N-acyl-n'-benzyl-alkylendiamino derivatives App 20070142455 - Thaler; Florian ; et al.	2007-06-21
Azolylbenzamides and analogues and their use for treating osteoporosis Grant 7,220,769 - Farina , et al. May 22, 2	2007-05-22
Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents App 20070027137 - Farina; Carlo ; et al.	2007-02-01
Quinoline Derivatives as NK-3 and NK-2 Antagonists App 20070015766 - Farina; Carlo ; et al.	2007-01-18
3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists App 20060229315 - FARINA; Carlo ; et al.	2006-10-12
Quinoline Derivatives as NK-3 Antagonists App 20060223819 - Farina; Carlo ; et al.	2006-10-05
Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists App 20050176762 - Farina, Carlo ; et al.	2005-08-11
Indole derivatives for the treatment of osteoporosis Grant 6,903,117 - Farina , et al. June 7, 2	2005-06-07
Azolylbenzamides and analogues and their use for treating osteoporosis App 20050038095 - Farina, Carlo ; et al.	2005-02-17
Indole derivatives and their use for the treatment of osteoporosis amongst other applications App 20040235930 - Farina, Carlo ; et al.	2004-11-25
3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists App 20040180902 - Farina, Carlo ; et al.	2004-09-16
Indole derivatives and their use for the treatment of osteoporosis amongst other applications Grant 6,787,550 - Farina , et al. September 7, 2	2004-09-07
Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists App 20040152726 - Farina, Carlo ; et al.	2004-08-05
Quinoline derivatives as nk-3 antagonists App 20040097518 - Farina, Carlos ; et al.	2004-05-20
Quinoline derivatives as nk-3 and nk-2 antagonists App 20040082589 - Farina, Carlo ; et al.	2004-04-29
Morphinoid derivatives as delta-opioid agonists and antagonists App 20040067959 - Dondio, Giulio ; et al.	2004-04-08
Pyrrole-condensed morphinoid derivatives App 20040019070 - Dondio, Giulio ; et al.	2004-01-29
Indole derivatives for the treatment of osteoporosis App 20040010012 - Farina, Carlo ; et al.	2004-01-15
Indole derivatives for the treatment of osteoporosis App 20020173659 - Farina, Carlo ; et al.	2002-11-21
Indole derivatives useful A.O. for the treatment of osteoporosis App 20020099080 - Gagliardi, Stefania ; et al.	2002-07-25
Indole derivatives useful in the treatment of osteoporosis Grant 5,981,525 - Farina , et al. November 9, 1	1999-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.